- Home
- ORI vs BMRN Comparison
ORI vs BMRN Comparison
Compare ORI & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORI | BMRN |
|---|---|---|
| Founded | 1923 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 10.5B |
| IPO Year | 1994 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ORI | BMRN |
|---|---|---|
| Price | $40.22 | $53.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 18 |
| Target Price | $42.50 | ★ $88.22 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 14.81 | N/A |
| EPS | ★ 3.72 | 1.80 |
| Revenue | ★ $9,136,300,000.00 | $1,313,646,000.00 |
| Revenue This Year | $7.07 | $15.02 |
| Revenue Next Year | $6.86 | $12.23 |
| P/E Ratio | ★ $10.76 | $29.96 |
| Revenue Growth | 10.99 | ★ 17.62 |
| 52 Week Low | $35.60 | $50.76 |
| 52 Week High | $46.76 | $66.28 |
Technical Indicators
Market Signals| Indicator | ORI | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 36.38 |
| Support Level | $38.75 | $51.54 |
| Resistance Level | $41.59 | $56.21 |
| Average True Range (ATR) | 0.94 | 1.30 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 20.41 | 2.87 |
Price Performance
Historical ComparisonAbout ORI Old Republic International Corporation
Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.